# Innate Pharma SA: Form 6-K, filed Sep 14, 2023

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 6-K
- Filed: 2023-09-14
- Accepted by EDGAR: Sep 14, 2023, 06:27 ET
- Period: 2023-06-30
- Accession: 0001628280-23-032230
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000162828023032230/inpha-20230630_d2.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000162828023032230/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000162828023032230/inpha-20230630_d2.htm

Filed Sep 14, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-032230. Last ingested by Listed: Nov 5, 2026, 11:30 ET. No prices; not investment advice.